106 related articles for article (PubMed ID: 1398278)
21. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia.
Bettelheim P; Valent P; Andreeff M; Tafuri A; Haimi J; Gorischek C; Muhm M; Sillaber C; Haas O; Vieder L
Blood; 1991 Feb; 77(4):700-11. PubMed ID: 1993213
[TBL] [Abstract][Full Text] [Related]
22. In vivo effect of granulocyte-macrophage colony-stimulating factor on the kinetics of human acute myeloid leukemia cells.
Aglietta M; De Felice L; Stacchini A; Petti MC; Bianchi AC; Aloe Spiriti MA; Sanavio F; Apra F; Piacibello W; Stern AC
Leukemia; 1991 Nov; 5(11):979-84. PubMed ID: 1961040
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte-macrophage colony-stimulating factor in acute non-lymphocytic leukemia before and after chemotherapy.
Visani G; Damiani D; Cenacchi A; Russo D; Revignas G; Gamberi B; Fanin R; Fogli M; Baccarani M; Tura S
Ann Hematol; 1991 Nov; 63(5):276-81. PubMed ID: 1958752
[TBL] [Abstract][Full Text] [Related]
24. Granulocyte-macrophage colony stimulating factor in acute non-lymphocytic leukaemia.
Fanin R; Baccarani M
J Intern Med; 1994 Nov; 236(5):487-93. PubMed ID: 7964423
[TBL] [Abstract][Full Text] [Related]
25. Fatal spleen rupture during induction chemotherapy with rh GM-CSF priming for acute monocytic leukemia. Clinical case report and in vitro studies.
Zimmer BM; Berdel WE; Ludwig WD; Notter M; Reufi B; Thiel E
Leuk Res; 1993 Mar; 17(3):277-83. PubMed ID: 8450676
[TBL] [Abstract][Full Text] [Related]
26. Reversible leukaemic regrowth under GM-CSF treatment after chemotherapy for AML.
Koenigsmann M; Hiddemann W; Büchner T
Leuk Res; 1991; 15(1):37-41. PubMed ID: 1997744
[TBL] [Abstract][Full Text] [Related]
27. A pilot study of the biologic and therapeutic effects of granulocyte colony-stimulating factor (filgrastim) in patients with acute myelogenous leukemia.
Jakubowski A; Gordon M; Tafuri A; Schuster S; Andreeff M; Shieh JH; Vincent M; Gabrilove J
Leukemia; 1995 Nov; 9(11):1799-804. PubMed ID: 7475265
[TBL] [Abstract][Full Text] [Related]
28. Treatment of relapsed acute myeloid leukemia using GM-CSF before intensive chemotherapy.
Puntous M; Lacombe F; Dumain P; Marit G; Cony-Makhoul P; Belloc F; Boiron JM; Laurent G; Bernard P; Reiffers J
Leuk Lymphoma; 1993 Dec; 12(1-2):95-102. PubMed ID: 8161939
[TBL] [Abstract][Full Text] [Related]
29. Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts.
Valent P; Sillaber C; Geissler K; Andreeff M; Tafuri A; Vieder L; Schulz G; Lechner K; Bettelheim P
Med Pediatr Oncol Suppl; 1992; 2():18-22. PubMed ID: 1306881
[TBL] [Abstract][Full Text] [Related]
30. Assessment of proliferative responses to granulocyte-macrophage colony-stimulating factor (GM-CSF) in acute myeloid leukaemia using a fluorescent ligand for the nucleoside transporter.
Wiley JS; Cebon JS; Jamieson GP; Szer J; Gibson J; Woodruff RK; McKendrick JJ; Sheridan WP; Biggs JC; Snook MB
Leukemia; 1994 Jan; 8(1):181-5. PubMed ID: 8289485
[TBL] [Abstract][Full Text] [Related]
31. Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil kinetics and function in normal human volunteers.
Dale DC; Liles WC; Llewellyn C; Price TH
Am J Hematol; 1998 Jan; 57(1):7-15. PubMed ID: 9423810
[TBL] [Abstract][Full Text] [Related]
32. Effects of rhGM-CSF on myeloid clonogenic cells in acute myelogenous leukemia patients.
Preisler H; Larson R; Banavali S; Yin M; Li YQ; Banerjee M; Gopal V; Raza A
Leuk Lymphoma; 1993 Jun; 10(3):183-6. PubMed ID: 8220116
[TBL] [Abstract][Full Text] [Related]
33. Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapy.
Valent P; Sillaber C; Geissler K; Andreeff M; Tafuri A; Vieder L; Schulz G; Lechner K; Bettelheim P
Cancer Invest; 1993; 11(2):229-34. PubMed ID: 8462024
[No Abstract] [Full Text] [Related]
34. Acute myeloid leukaemia with abnormal eosinophil precursors without inversion 16.
Rashidi A; Roullet MR
Br J Haematol; 2012 Sep; 158(5):561. PubMed ID: 22758220
[No Abstract] [Full Text] [Related]
35. Short-term myeloid growth factor mediated expansion of bone marrow haemopoiesis studied by localized magnetic resonance proton spectroscopy.
Jensen KE; Hansen PB; Larsen VA; Johnsen HE; Nielsen H; Karle H; Henriksen O
Br J Haematol; 1994 Nov; 88(3):465-71. PubMed ID: 7529528
[TBL] [Abstract][Full Text] [Related]
36. [Acute myeloid leukemias: role of growth factors to improve the efficacy of chemotherapy].
Viallard JF; David S; Grosset C; Puntous M; Lacombe F; Reiffers J
Presse Med; 1995 May 6-13; 24(17):822-6. PubMed ID: 7543203
[TBL] [Abstract][Full Text] [Related]
37. New emerging applications of molgramostim in acute myeloid leukaemia.
Thomas X
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):795-806. PubMed ID: 18611119
[TBL] [Abstract][Full Text] [Related]
38. Treatment of acute leukaemia: implications of recent findings in cell biology.
Benestad HB
Folia Biol (Praha); 1978; 24(1):1-15. PubMed ID: 273000
[TBL] [Abstract][Full Text] [Related]
39. Current problems in the treatment of acute myelocytic leukemia (AML) and some possible solutions.
Preisler HD; Raza A
Leukemia; 1992; 6 Suppl 2():81-4. PubMed ID: 1578951
[No Abstract] [Full Text] [Related]
40. Unexpected remission of acute myeloid leukaemia after GM-CSF.
Bassan R; Rambaldi A; Amaru R; Motta T; Barbui T
Br J Haematol; 1994 Aug; 87(4):835-8. PubMed ID: 7986724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
